Childhood Acute Lymphoblastic Leukemia — Trials

Childhood Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

401 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 6%
Top sponsor: Nationwide Children's Hospital
Termination share: 14%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04881240	Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia	recruiting	Phase 1	60	St. Jude Children's Research HospitalOTHER	1	Aug 31, 2026	clinicaltrials
NCT07257419	CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma	recruiting	Phase 1	70	St. Jude Children's Research HospitalOTHER	1	Aug 28, 2026